The state of the hunt:Vaccine candidates from Novavax and J&J’s Janssen subsidiary entered Phase 3.
Chinese regulators are reviewing inactivated vaccine candidates from CNBG for conditional authorization.
Fujifilm’s flu drug Avigan (favipiravir) met its primary endpoint in a Phase 3 trial for treatment of Covid-19.
Phase 3 candidates:
China weighs approval of CNBG shots: State regulators are reviewing CNBG’s two…